Endometrial Local Injury Before First IVF : Evaluation of Pregnancy Rate
NCT ID: NCT02522806
Last Updated: 2019-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
315 participants
INTERVENTIONAL
2014-09-23
2019-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Different causes may account for these failures and that, during all stages of pregnancy.
Recent studies have investigated an essential step in fecundation : uterine receptivity. Some teams have shown that a lot of immunological factors would have very significant in this step, by them possible expression in this process. Other studies looked at genes modulation, essential to implantation, with endometrium manipulation, simple, such as endometrial biopsy (EB). The last findings published on this subject, but after 2 IVF failures, are most encouraging because the pregnancy rate for these teams after just endometrial local injury (EB after 2 IVF failures) is well above their usual pregnancy rate. Some teams have focused on immunoassay of endometrial biopsy, in order to profile uterine receptivity and suggest with results, suitable treatment for each patient (ongoing study).
EB is quick, easy, make in a simple consultation and with a low cost, contrary to immunological study, which depend of ultra-specialized laboratories and therefore with an important cost.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Local Biopsy to the Endometrium Prior to Controlled Ovarian Stimulation on Clinical Pregnancy
NCT01064193
Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles
NCT01798862
Local Endometrial Injury in Fresh Embryo Transfer Cycles
NCT01844453
Endometrial Injury and in Vitro Fertilization Outcomes
NCT02153814
Endometrial Injury Increases Implantation and Pregnancy Rates
NCT01340560
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Endometrial biopsy (EB) between J17 and J22 of previous ovarian hyperstimulation cycle.
endometrial biopsy
Endometrial biopsy (EB) between J17 and J22 of previous ovarian hyperstimulation cycle
Group B
none endometrial biopsy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
endometrial biopsy
Endometrial biopsy (EB) between J17 and J22 of previous ovarian hyperstimulation cycle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acceptance of protocol by patient after free and complete information and signature of consent.
* Anti-Mullerian Hormone (AMH ) greater than 1
* Member or eligible to social security system
* Availabilities for a follow up 2 or 12 months.
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne GENOD, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de SAINT-ETIENNE
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-A01003-44
Identifier Type: OTHER
Identifier Source: secondary_id
1408062
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.